Legislative and News Updates

Florida Is Trying to Make Brazilian Butt Lifts Less Deadly

August 30, 2022

Click Here To Read Article

Clarification on Executive Order 20-72

March 2020
The Governor’s Executive Order applies to all physicians performing any procedure in a hospital, ambulatory surgical center, office surgery center, or in their office. The Executive Order prohibits physicians from “providing any medically unnecessary, non-urgent or non-emergency procedure or surgery which, if delayed, does not place a patient’s immediate health, safety, or well-being at risk, or will, if delayed, not contribute to the worsening of a serious or life-threatening medical condition.”
According to the Department of Health, this order prohibits ANY medically unnecessary, non-urgent or non-emergency procedure performed in a physician’s office, not just those procedures that consume essential resources (such as personal protective equipment).
A “procedure” is any medical treatment or operation, including, but not limited to, injections, ablations, laser procedures, physical therapy, cosmetic procedures, allergy shots, etc.
The provision of in-person medical treatment of any nature is a “procedure” and thus must be postponed if doing so does not place the patient’s immediate health, safety or well-being at risk or will not contribute to the worsening of a serious or life-threatening medical condition.
Physicians can continue to see patients for purposes of evaluation and management, including the performance of a physical examination, in order to determine if they have a medical condition that needs immediate attention. Physicians, to the extent possible, should use telemedicine services to pre-screen patients so that those with clearly non-emergency conditions do not have to come to the office for evaluation. Telemedicine, as previously stated, can continue unabated.
Further clarification from the Department of Health does not appear to be forthcoming. The Department currently will only state that:
“While some specific examples of which procedures should be postponed are also contained within Executive Order 20-72, licensed health care practitioners are tasked with exercising reasonable and appropriate professional judgment in evaluating their patients’ specific circumstances, overall health, and the medical necessity of any procedures performed. Therefore, the Executive Order explicitly leaves discretion on proceeding with procedures to the medical professional, based on his or her expertise and the specific factual situation of each patient. Only the medical professional can make that determination.”
Based on this limited direction then, each physician will have to make a judgment call on whether a particular procedure is necessary to avoid putting the patient’s immediate health, safety or well-being at risk or whether delaying such procedure will contribute to the worsening of a serious or life-threatening medical condition. If the physician determines that an interventional pain procedure, ongoing course of treatment, diagnostic test, etc. is necessary under the parameters set forth above, then the physician can perform the procedure. If the physician determines that the procedure can be safely delayed, the procedure should not be done.

Guidelines for Cutaneous Oncology Cases

The Moffitt Cancer Center Cutaneous Oncology Department have come up with some guidelines for care of cutaneous malignancies. They have also sent current NCCN Guidelines for treating BCC and SCC.
We hope you are all staying healthy and safe right now!
Cutaneous Oncology Care Guidelines:
1.   Urgent: currently stable but at significant risk of worsening if not treated within the next month, psychologically or physically unsuited to a delay in treatment. Care should not be delayed >30 days.
2.   Non-urgent: currently stable and likely to remain so even if intervention is deferred for more than a month without anticipated psychological or physical harm. Care can be delayed >30 days.
3.   Elective: involving treatment for a benign condition (eg, lipomas) or a non-time critical nontherapeutic procedure such as scar revisions. Care can be delayed for many months.
4. Critical/Emergent: unstable, unbearable suffering, and/or whose condition is immediately life threatening, very likely to deteriorate or progress if not treated immediately
**Fortunately in Cutaneous Oncology, we do almost nothing that falls into Critical/Emergent, and very little that consumes resources most likely to become scarce in the near future (blood products, ventilators, ICU beds and even inpatient hospital beds).
Urgent: All invasive melanomas, Merkel cell carcinomas, cutaneous sarcomas, adnexal carcinomas, locally advanced basal and squamous cell carcinomas (>2 cm, fixed to underlying structures, actively bleeding, etc)
Non-urgent: Melanoma in situ, non-transformed DFSP (not locally advanced), “high-risk” basal and squamous cell carcinomas (using the NCCN criteria for high risk that include size, location, recurrence, etc)
Elective: Low-risk basal and squamous cell carcinomas and squamous cell carcinoma in situ; reexcision of atypical nevi with positive margins, surgery for benign conditions (eg, lipomas), scar revisions and elective reconstructive surgeries.

New BCBSF Policy

2019 Legislative Wrap-Up

The Year of Scope
Led by House Speaker Jose Oliva, Scope of Practice bills dominated the 2020 Florida Legislative Session. Bills were filed that would have allowed Nurse Practitioners and Physician Assistants to practice independently, as well as allow pharmacists to practice primary care. Despite our fierce opposition, these proposals were passed in modified form, although our efforts did reduce the impact of this legislation.
For instance, while the initial legislation would have placed Nurse Practitioners and Physician Assistants on an equal footing with physicians, the final product only allows Nurse Practitioners to practice primary care without the supervision of a physician (any surgery would be limited to subcutaneous tissue), and then only if they meet additional training and experience requirements. The Pharmacy bills were modified to a lesser degree, and pharmacists will be allowed to test and treat for influenza, strep throat, and several other minor conditions so long as they have a physician protocol similar to that currently required of APRNs. While signed by the Governor, these initiatives both will require extensive rule making, so implementation will be delayed considerably.
Despite the Scope of Practice defeats, we were successful in many other areas. For instance, we defeated a proposal that would mandate e-prescribing (with no exceptions), as well a bill that would have required all practice mergers to be submitted to the Attorney General for approval. Likewise, we defeated a PIP proposal that would have eliminated the “physician set-aside” for such auto-accident cases.
As this year proves, advocacy cannot be measured simply in wins and losses, but must be measured by our ability to “move the needle.” While we certainly suffered legislative losses, thanks to the efforts of our staff and members, we were successful in averting the worst legislation, and we will come back next year with a renewed sense of purpose.
_______________________________________________________________________________________________
The Florida Legislature Wednesday passed two bills (HB 607 and HB 389), which allow APRNs to practice primary care without supervision, and allow pharmacists to test and treat for a variety of conditions. The FSPS is asking Governor Ron DeSantis to veto both of these flawed bills and has sent the attached letters asking for such a veto.
The FSPS is asking each of you, as concerned physicians, to write similar letters to the Governor asking that he veto both bills, but especially HB 607. While our lobbying restricts APRNs to subcutaneous surgery related to primary care, we are fully aware that our opponents want to expand their practice even further next year.

February 2020 

Week Seven Update
February 29, 2020

OUR BACKS AGAINST THE WALL

With only fourteen days left in the Legislative Session, 2020 is likely to be remembered as the year that the Florida Legislature declared war on Medicine. Just this week, the House of Representatives moved measures to the Floor that would grant independent practice to APRNs and PAs (actually, they passed it twice, in HB 607 and HB 7053) and allow pharmacists to test and treat for a variety of chronic health conditions (HB 389 and HB 599). These moves were in addition to passing legislation, which now moves to the Senate, that would mandate electronic prescribing of all prescriptions (even if the physician does not have an electronic medical record system), require Attorney General approval of most physician mergers, and shorten the time frames in which physicians must produce medical records.
For years, the Senate has been the firewall against such Anti-Physician legislation, but that wall has crumbled in recent weeks. Just this week, the Senate moved to the Floor legislation that would allow pharmacists to test and treat for the flu (SB 714), and an Independent Practice Bill (SB 1676) and expanded Pharmacist Scope (SB 1094) are only a single committee stop away from a full floor vote. While the current Senate versions of each of these bills is far superior than the House counterparts, the fact that each is likely to pass raises the likelihood that a deal will be worked out in all such issues, with the House taking the lead on the discussions.
The actions of the House are now a foregone conclusion, but we still have some support in the Senate. If you care about these issues, NOW is the time to contact your Senator by going to www.flsenate.gov to contact their Senator and ask them to vote NO on these Scope Expansion Bills.

Week Five Legislative Update

February 14, 2020
On this 2020 Valentines Day, the Florida House is showing no love to physicians, and what appeared to be a solid firewall in the Senate is now showing cracks.
In the House, the Health and Human Services Committee on Wednesday voted to place restrictions on physician mergers (HB 711), require physicians to ensure that referrals are made within an MCO network (HB 955), and require greater and quicker access to patient records (HB 1147). Moreover, bills to allow increased Scope of Practice for Pharmacists (HB 599) and APRNs and PAs (HB 607) are poised for action next week.
In the Senate, it is rumored that the Senate Health Policy Committee will, indeed, consider at least some Scope of Practice expansion next week, particularly with regard to Consultant Pharmacists working in hospitals and nursing homes.
Not all of the news is bad. The House Health and Human Services Committee did advance HB 309 (Restrictions on the Use of Physician Terms) to the Floor, and this far we have been able to deflect attacks on the Physician Use of Office Surgery (with Special thanks to Senator Anitere Flores on that one).
While the threats to Medicine are real, we are well-prepared for the fights that lie ahead. Please be on the watch for Call to Action in the next several weeks, as we will be “pulling out all the stops” to protect the Practice of Medicine.

January 2020 

Week One Legislative Report
So Much for the Preliminaries…
While legislative sessions usually start slowly and accelerate, 2020 has proven to be an exception, especially for Medicine. Scope of Practice battles dominated the first week and will continue to do so in the second week.
On Tuesday, we won our first battle as the Senate Health Policy Committee passed SB 500, which protects the use of terms such as “internist,” gastroenterologist,” and “surgeon” to physicians. Any euphoria was short-lived, as Wednesday saw the House Health Appropriations Committee pass the APRN/PA Independent Practice Bill (HB 607) and the Pharmacist Flu/Strep Test and Treat Bill (HB 389), each of which now only has one committee stop remaining. Meanwhile, on the same day the House Health Quality Committee voted (over our strenuous objections) to remove exceptions to Mandatory E-Prescribing (HB 1103).
Next week promises to be just as busy. On Tuesday alone, The House Health Quality Committee will consider a proposed Pharmacist Scope of Practice expansion (HB 599), the House Health Appropriations Committee will consider our “Use of Physician Terms” Bill (HB 309), the Senate Banking and Insurance Committee will consider a bill to further regulate Pharmacy Benefit Managers (SB 1338), and the House Health Market Reform Committee will consider a bill to improve Health Care Price Transparency (HB 1205).
As always, a big “Thank You” goes out to all of our physicians who contact their legislators on these important issues, especially during the eight weeks to come.
Week 2 Legislative Report
As the second week of the 2020 Legislative Session winds down, it has become apparent where the two chambers appear to be headed on major issues.
On Scope of Practice issues, the House appears to be poised to pass Independent Practice for APRNs and PAs, as HB 607 passed Health Appropriations easily and now moves on to its last stop, the Health and Human Services Committee. Likewise, the Pharmacist Flu/Strep Test and Treat bill (HB 389) and Consultant Pharmacist Bill (HB 599) have all moved to the Health and Human Services Committee, which will meet next week. On a better note, the Health Appropriations Committee did pass HB 500, which would prevent the misappropriation of physician titles (such as “surgeon” or “internist”) by other professions. Meanwhile, the Senate thus far is refusing to consider such proposals, which likely will set the stage for late-session negotiations.
Pharmaceutical and PBM misconduct received its first hearing this week, with the Health Reform Committee passing its first PBM bill that would require greater transparency from such organizations, but would not include patient protections for which we are lobbying. The Senate will address the issue of the first time next week.
Next week will be an intense one, as Tuesday alone will feature hearings from the Senate Health Policy Committee and Banking and Insurance Committee, while the House Health Quality Committee and Health Market Reform Committees both will be meeting.
Keep in touch with your concerns, and I will stay in touch with you.